1 results match your criteria: "Head of Clinical Research Medical Affairs Department[Affiliation]"
Bilastine 10 and 20 mg in paediatric and adult patients: an updated practical approach to treatment decisions.
Drugs Context
August 2021
Head of Clinical Research Medical Affairs Department, Faes Farma SA, Bizkaia, Spain.
Background: Bilastine, a non-sedating H-antihistamine, is indicated to treat the symptoms of allergic disorders (e.g. rhinoconjunctivitis and urticaria) in adults and adolescents and, more recently, in children.
View Article and Find Full Text PDF